Publications

Prediction of relapse-free survival according to adjuvant chemotherapy and regulator of chromosome condensation 2 (RCC2) expression in colorectal cancer

Bergsland, C. H., Bruun, J., Guren, M. G., Svindland, A., Bjørnslett, M., Smeby, J., Hektoen, M., Kolberg, M., Domingo, E., Pellinen, T., Tomlinson, I., Kerr, D., Church, D. N., Nesbakken, A., Sveen, A., & Lothe, R. A. (2020). Prediction of relapse-free survival according to adjuvant chemotherapy and regulator of chromosome condensation 2 (RCC2) expression in colorectal cancer. ESMO open, 5(6), e001040. https://doi.org/10.1136/esmoopen-2020-001040

Prediction of relapse-free survival according to adjuvant chemotherapy and regulator of chromosome condensation 2 (RCC2) expression in colorectal cancer Read More »

ACE2 localizes to the respiratory cilia and is not increased by ACE inhibitors or ARBs

Lee, I. T., Nakayama, T., Wu, C. T., Goltsev, Y., Jiang, S., Gall, P. A., Liao, C. K., Shih, L. C., Schürch, C. M., McIlwain, D. R., Chu, P., Borchard, N. A., Zarabanda, D., Dholakia, S. S., Yang, A., Kim, D., Chen, H., Kanie, T., Lin, C. D., Tsai, M. H., … Jackson, P. K. (2020). ACE2 localizes to the respiratory cilia and is not increased by ACE inhibitors or ARBs. Nature communications, 11(1), 5453. https://doi.org/10.1038/s41467-020-19145-6

ACE2 localizes to the respiratory cilia and is not increased by ACE inhibitors or ARBs Read More »

Evaluating the efficacy of enzalutamide and the development of resistance in a preclinical mouse model of type-I endometrial carcinoma

Koivisto, C. S., Parrish, M., Bonala, S. B., Ngoi, S., Torres, A., Gallagher, J., … & Cohn, D. E. (2020). Evaluating the efficacy of enzalutamide and the development of resistance in a preclinical mouse model of type-I endometrial carcinoma. Neoplasia, 22(10), 484-496.

Evaluating the efficacy of enzalutamide and the development of resistance in a preclinical mouse model of type-I endometrial carcinoma Read More »

The prognostic role of macrophage polarization in the colorectal cancer microenvironment.

Väyrynen, J. P., Haruki, K., Lau, M. C., Väyrynen, S. A., Zhong, R., Dias Costa, A., Borowsky, J., Zhao, M., Fujiyoshi, K., Arima, K., Twombly, T. S., Kishikawa, J., Gu, S., Aminmozaffari, S., Shi, S., Baba, Y., Akimoto, N., Ugai, T., Da Silva, A., Guerriero, J. L., … Nowak, J. A. (2021). The Prognostic Role of Macrophage Polarization in the Colorectal Cancer Microenvironment. Cancer immunology research, 9(1), 8–19. https://doi.org/10.1158/2326-6066.CIR-20-0527

The prognostic role of macrophage polarization in the colorectal cancer microenvironment. Read More »

Clusters of Tolerogenic B Cells Feature in the Dynamic Immunological Landscape of the Pregnant Uterus

Benner, M., Feyaerts, D., García, C. C., Inci, N., López, S. C., Fasse, E., Shadmanfar, W., van der Heijden, O., Gorris, M., Joosten, I., Ferwerda, G., & van der Molen, R. G. (2020). Clusters of Tolerogenic B Cells Feature in the Dynamic Immunological Landscape of the Pregnant Uterus. Cell reports, 32(13), 108204. https://doi.org/10.1016/j.celrep.2020.108204

Clusters of Tolerogenic B Cells Feature in the Dynamic Immunological Landscape of the Pregnant Uterus Read More »

Spatial Density and Distribution of Tumor-Associated Macrophages Predict Survival in Non-Small-Cell Lung Carcinoma.

Zheng, X., Weigert, A., Reu, S., Guenther, S., Mansouri, S., Bassaly, B., … & Winter, H. (2020). Spatial Density and Distribution of Tumor-Associated Macrophages Predict Survival in Non–Small Cell Lung Carcinoma. Cancer Research, 80(20), 4414-4425.

Spatial Density and Distribution of Tumor-Associated Macrophages Predict Survival in Non-Small-Cell Lung Carcinoma. Read More »

The Capacity of the Ovarian Cancer Tumor Microenvironment to Integrate Inflammation Signaling Conveys a Shorter Disease-free Interval

Jordan, K. R., Sikora, M. J., Slansky, J. E., Minic, A., Richer, J. K., Moroney, M. R., Hu, J., Wolsky, R. J., Watson, Z. L., Yamamoto, T. M., Costello, J. C., Clauset, A., Behbakht, K., Kumar, T. R., & Bitler, B. G. (2020). The Capacity of the Ovarian Cancer Tumor Microenvironment to Integrate Inflammation Signaling Conveys a Shorter Disease-free Interval. Clinical cancer research : an official journal of the American Association for Cancer Research, 26(23), 6362–6373. https://doi.org/10.1158/1078-0432.CCR-20-1762

The Capacity of the Ovarian Cancer Tumor Microenvironment to Integrate Inflammation Signaling Conveys a Shorter Disease-free Interval Read More »

Occult colonic perforation in a patient with COVID-19 following interleukin-6 receptor antagonist therapy

Schwab, K., Hamidi, S., Chung, A., Lim, R. J., Khanlou, N., Hoesterey, D., Dumitras, C., Adeyiga, O. B., Phan-Tang, M., Wang, T. S., Saggar, R., Goldstein, J., Belperio, J. A., Dubinett, S. M., Kim, J. T., & Salehi-Rad, R. (2020). Occult Colonic Perforation in a Patient With Coronavirus Disease 2019 After Interleukin-6 Receptor Antagonist Therapy. Open forum infectious diseases, 7(11), ofaa424. https://doi.org/10.1093/ofid/ofaa424

Occult colonic perforation in a patient with COVID-19 following interleukin-6 receptor antagonist therapy Read More »